Immunofusion’s first-in-class fifth-generation CAR T-cell therapy combines precise tumor-specific targeting and T-cell signaling rewiring to cure CLL and MCL safely, designed to achieve lasting remission with fewer risks
Company Details
- Employees
- 1
- Founded
- -
- Address
- Vilnius, Lt
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://immunofusion.com
- Keywords
- (AWS).
- HQ
- Vilnius
Immunofusion Questions
Immunofusion's website is http://immunofusion.com
Immunofusion's LinkedIn profile is https://lt.linkedin.com/company/immunofusion
Immunofusion has
1 employees.
View email and phone details for 1
employees at Immunofusion.
Immunofusion's industry is
Biotechnology Research
Immunofusion's top competitors are
Hemastatx,
Digestaid - Digestive Artificial Intelligence Development,
Polirna,
Stellaris Therapeutics,
Signatur Biosciences,
Kinetic Cortex,
Antegenes,
Adipopharma Sas,
Mestastop® Solutions,
Oncorna.
Immunofusion's categories are Biotechnology Research
Immunofusion's founding year is 2021
